1Kenneth J,Pienta and David C. Smith. Advanced in prostate cancer cheroot herarapy: Anew era begins [J ]. CA Cancer J Clin,2005,55(1) :300.
2A Wardley, N Davidson, P Barrett-Lee, etal. Zoledronic acid significantly improves pain scores and quality of life breast cancer patients with bone metastases :a randomized, cross over study of community vs hospital bisphosphonate administration[J]. Birtish Journal of Cancer,2005,92(2):1869.
3Nakajima H,Magae J,TsurugaM.et al. Induction of mitochondria dependent apop tosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529,a new third generation bisphosphonate[J].Cancer Lett, 2007, 253 (1):89.
4Baulch Brown C,Molloy T J,Yeh SL,et al. Inhibitors of the mevalonate pathway as potential therapeutic agents in multip e myeloma[J]. Leuk Res,2007,31 (3):341.
5Koshimune R,AoeM,Toyooka S,et al. Anti2tumor effect of bisphosphonate (YM529)on non - small cell lung cancer cell lines[J]. BMC Cancer,2007.43(7):8.
6Von Lilienfeld Toal M, Sievers E, Bodemller V, et al. Cocuhure with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells[J]. Immunol Lett. 2005,99(1) :103.
7Coxon JP, Oades GM, Ki rby RS. et al. Zoledronic acid induces apptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation[J].BJUInt,2004,94(1):164.
8Green JR,Clezardin P. Mechanism of bisphosphonate effect on osteoclasts, tumor cell growth, and metastasis[J]. Am J Clin Oncol,2002,25(6 suppl 1):S3.
9Ingo J. Diel Antitumor Effects of Bisphosphonates First Evidence and possible Mechanisms[J]. Drugs 2000,59(3);391.
10Masahiro Abe, Keriyi Hiura,Jarier Wilde. etal. Osteoclasts enhance myeloma cell growth and survival via ceil cell con tact : a vicious cycle between bone destruction and myeloma expansion[J]. Blood. 2004,104 (3) : 2484.
4Schmidt J, Mcclain C J. Separation of o-Phthalaldehyde-Mercaptoethanol Derivatives of Amino Acids from Blood Plasma on Reversed-Phase Nova- Pak Cls Cartridges[J]. Chromatography, 1991,568(1) : 207--211.
5Fleury M O, Ashley D V. High-Performance Liquid Chromatographic Analysis of Amino Acids in Physiological Fluids:On-Line Precolumn Derivatization with o-Phthalaldehyde[J]. Analytical Biochemistry, 1983,133(2) : 330--335.
6Rowley H L, Martin K F, Marsden C A. Determination of in Vivo Amino Acid Neurotransmitters by High-Performance Liquid Chromatography with o-Phthalaldehyde-Sulphlte Derivatization[J]. Neuroscience Methods,1995,57(1) :93--99.
7Dorresteijn R C, Berwald L G, Zomer Get al. Determination of Amino Acids Using o-Phthalaldehyde-2-Mercaptoethanol Derivatization Effect of Reaction Conditions[J]. Chromatography A,1996,724(1--2)159--167.
8Bechard S R. Dry Mix Formulation For Bisphoshonie Acids With Laetose[P]. Kenneth A. Kramer,Ashok V. Katdare. United States Patent. 5 358 941. 1994-10-25.
9A1 Deeb S K. , Hamdan I I,AI Najjar S M. Spectroqeopic and HPLC Methods for the Determination of Alendronate in Tablets and Urine[J ]. Talanta, 2004,64(3) : 695--702.
10Piepponen T P,Skujins A. Rapid and Sensitive Step Gradient Assays of Glutamate,Glycine,Taurine and g-Aminobutyric Acid by High Performance Liquid Chromatography-Fluorescence Detection with o-Phthalaldehyde-Mercaptoethanol Derivatization with an Emphasis on Microdialysis[J]. Chrtnnatography B,2001,757(2) :277--283.
